Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Cell Biotech Co., Ltd. (049960:KRX), powered by AI.
Cell Biotech Co., Ltd. is currently trading at ₩16,340. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Cell Biotech Co., Ltd. on Alpha Lenz.
Cell Biotech Co., Ltd.'s P/E ratio is 15.2.
“Cell Biotech Co., Ltd. trades at a P/E of 15.2 (fair value) with modest ROE of 7.9%.”
Ask for details →Cell Biotech Co., Ltd. is a biotechnology company primarily focused on the research, development, and production of probiotic products. It serves the healthcare industry by providing innovative solutions designed to support digestive health and enhance overall wellness. Cell Biotech is well-known for its proprietary probiotic strains, which are utilized in various applications ranging from dietary supplements to functional foods. The company’s products are directed towards improving gut health, which plays a critical role in maintaining immune system function and overall bodily health. Cell Biotech's operations demonstrate its commitment to advancing scientific understanding and application of probiotics, making it a key player in sectors that emphasize sustainable health and wellness solutions. In the broader market, Cell Biotech Co., Ltd. is recognized for contributing significantly to the growing consumer demand for natural health products, positioning itself as an influential entity within the global biotechnology and nutraceutical industries.
“Cell Biotech Co., Ltd. trades at a P/E of 15.2 (fair value) with modest ROE of 7.9%.”
Ask for details →Cell Biotech Co., Ltd. (ticker: 049960) is a company listed on KRX in the Common Stock sector (Common Stock). Market cap is $153.6B.
The current price is ₩16,340 with a P/E ratio of 15.17x and P/B of 1.17x.
ROE is 7.92% and operating margin is 14.90%. Annual revenue is $53.1B.